Medical Research
(H30)
990 on File
TRS CANCER FIGHTERS INC
Financial strength (30%)
54/100
Reliability (20%)
50/100
Effectiveness (25%)
45/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$188K
Total Revenue
$165K
Total Expenses
$186K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
40.8%
Fundraising Efficiency
N/A
Operating Reserve
13.55x
Liability-to-Asset
2.4%
Revenue Diversification
99.9%
Compared with Peers
FY 2023
Compared with 1,004 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
40.8% | 86.3% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
0.4% | 10.6% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
58.9% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.6 mo | 13.1 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.4% | 0.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.9% | 95.3% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
5.9% | 4.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
27.2% | 12.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
12.3% | -0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $188K | $165K | $186K | 40.8% | 0 |
| 2022 | $178K | $130K | $163K | 25.9% | 0 |
| 2021 | $433K | $149K | N/A | — | 0 |
| 2019 | $129K | $145K | N/A | — | 0 |
| 2018 | $129K | $145K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.